Search

Search Results

• CLASSICAL HODGKIN LYMPHOMA TODAY

  Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.055

  926

  PDF: 550

  HTML: 212

• PATHOBIOLOGY OF HODGKIN LYMPHOMA

  Claudio Agostinelli, Stefano Pileri

  e2014040

  2014-06-05

  https://doi.org/10.4084/mjhid.2014.040

  3392

  PDF: 1547

  HTML: 5972

  Fig1-Ag-Pil: 280

  Ag-Pil Fig.2: 279

• The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

  Michele Bibas

  e2024015

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.015

  2532

  PDF: 1806

  HTML: 1037

• PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

  Michele Bibas

  e2024007

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.007

  3752

  PDF: 2620

  HTML: 1661

• HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

  Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré

  e2014050

  2014-07-01

  https://doi.org/10.4084/mjhid.2014.050

  3030

  PDF: 1438

  HTML: 3730

  Untitled: 232

  Untitled: 246

  Untitled: 211

• SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

  Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca

  e2016062

  2016-11-06

  https://doi.org/10.4084/mjhid.2016.062

  3900

  PDF: 1129

  HTML: 2554

• PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA

  Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus

  e2014053

  2014-07-04

  https://doi.org/10.4084/mjhid.2014.053

  3504

  PDF: 2072

  HTML: 7580

• EBV AND HIV-RELATED LYMPHOMA

  Michele Bibas, Andrea Antinori

  e2009032

  2009-12-29

  https://doi.org/10.4084/mjhid.2009.032

  1681

  PDF: 678

  HTML: 7210

• CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

  Luca Castagna, Carmelo Carlo-Stella, Rita Mazza, Armando Santoro

  e2015015

  2015-02-12

  https://doi.org/10.4084/mjhid.2015.015

  2896

  PDF: 1467

  HTML: 4686

• FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT

  Alessia Castellino, Umberto Vitolo

  e2017009

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.009

  4707

  PDF: 1714

  HTML: 4310

  Tables and Images: 278

• EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

  Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

  e2024042

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.042

  4652

  PDF: 1803

  HTML: 1294

• PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries

  Dr, Moleti, Anna Maria Testi

  e2024078

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.078

  1383

  PDF: 964

  HTML: 345

• AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

  Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori

  e2012075

  2012-11-07

  https://doi.org/10.4084/mjhid.2012.075

  2712

  PDF: 927

  HTML: 2138

• ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY

  Eldad J Dann

  e2014063

  2014-09-05

  https://doi.org/10.4084/mjhid.2014.063

  2215

  PDF: 1375

  HTML: 3517

• EBV IN HODGKIN LYMPHOMA

  Giuseppina Massini, Doerte Siemer, Stefan Hohaus

  e2009013

  https://doi.org/10.4084/mjhid.2009.013

  1750

  PDF: 644

  HTML: 14153

• EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN

  Massimiliano Salati, Marina Cesaretti, Matteo Macchia, Mufid El Mistiri, Massimo Federico

  e2014048

  2014-06-29

  https://doi.org/10.4084/mjhid.2014.048

  3793

  PDF: 1292

  HTML: 5094

  Incidence age-standardized rates for HL across the Mediterranean basin: 251

• I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS

  guangliang Chen

  e2021053

  2021-08-28

  https://doi.org/10.4084/MJHID.2021.053

  1274

  PDF: 549

  HTML: 418

• INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?

  Francesco Zallio, Giulia Limberti, Marco Ladetto

  e2017035

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.035

  3401

  PDF: 1101

  HTML: 2441

• THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA

  Umberto Ricardi, Andrea Riccardo Filippi, Cristina Piva, Pierfrancesco Franco

  e2014035

  2014-05-30

  https://doi.org/10.4084/mjhid.2014.035

  2341

  PDF: 1005

  HTML: 6865

  Figure 1: 210

• ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Angelo Michele Carella

  e2012059

  2012-10-02

  https://doi.org/10.4084/mjhid.2012.059

  2140

  PDF: 911

  HTML: 1107

• FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

  Andrea Gallamini, Anna Borra

  e2017029

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.029

  3414

  PDF: 1329

  HTML: 2370

• Persistent Fever and Splenic Abscess-like Lesions: A Diagnostic Trap in a Young Adult

  Chu Ee Seow, Siti Nur Atiqah Alwi, Nor Syazana Jamali, Sukanya Banerjee Nair

  e2026063

  2026-09-01

  https://doi.org/10.4084/MJHID.2026.063

  90

  PDF: 72

  Suppl. Files: 21

  Html: 58

  Html Suppl. Files: 13

• IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

  Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi

  e2017010

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.010

  3556

  PDF: 1355

  HTML: 2380

  Fi.1 Gritti.Rambaldi: 254

• Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India

  Mary Theresa Sylvia, Biswajit Dey, Debdatta Basu, Sajini Elizabeth Jacob, Rakhee Kar, Biswajit Dubashi

  e2016060

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.060

  3564

  PDF: 847

  HTML: 3029

  Figure 1a and 1b: 189

  Figure 2: 201

  Figure 3: 210

  Figure 4: 196

  Figure 5: 199

  Tables 1-5: 177

• COMPARATIVE EVALUATION OF BONE MARROW ASPIRATE WITH TREPHINE BIOPSY IN HEMATOLOGICAL DISORDERS AND DETERMINATION OF OPTIMUM TREPHINE LENGTH IN LYMPHOMA INFILTRATION

  Surbhi Goyal, Usha Rani Singh, Usha Rusia

  e2014002

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.002

  2115

  PDF: 1135

  HTML: 52086

• THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS

  Alessia Bari, Luigi Marcheselli, Raffaella Marcheselli, Eliana Valentina Liardo, Samantha Pozzi, Stefano Sacchi

  e2011065

  2011-12-20

  https://doi.org/10.4084/mjhid.2011.065

  2787

  PDF: 817

  HTML: 2332

• OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

  Paola Angelini, Laura Rodriguez, Mohammed Zolaly, Ahmed Naqvi, Sheila Weitzman, oussama Abla, Angela Punnett

  e2018020

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.020

  3062

  PDF: 894

  HTML: 431

• IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE

  Francesco Di Raimondo, Giorgio La Nasa

  e2014039

  2014-05-29

  https://doi.org/10.4084/mjhid.2014.039

  2310

  PDF: 1039

  HTML: 1986

• HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ

  Anna Maria Testi, Mazin Faisal Al-Jadiry, Maria Luisa Moleti, Stefania Uccini, Amir Fadhil Al-Darraij, Raghad Majid Al-Saeed, Hasanein Habeeb Ghali, Ahmed Hatem Sabhan, Samaher Abdulrazzaq Fadhil, Safaa Abdulelah Al-Badri, Adil Rabeea Alsaadawi, Ameer Dh Hameedi, Manhal Hashim Shanshal, Yasir Saadoon Al-Agele, Fatimah Abdul Ridha Al-Saffar, Nihal Khalid Yaseen, Alfonso Piciocchi, Giovanni Marsili, Salma Abbas Al-Hadad

  e2024053

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.053

  1143

  PDF: 977

  Suppl. Files: 623

  HTML: 109

• LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

  Andrea Riccardo Filippi

  e2016041

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.041

  3836

  PDF: 1169

  HTML: 2483

  Figure 1: 241

• THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA

  Dennis A Eichenauer, Andreas Engert

  e2011046

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.046

  2443

  PDF: 834

  HTML: 1265

• OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

  Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst

  e2023025

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.025

  1548

  HTML: 410

  PDF: 1010

  Suppl. Files: 506

• HHVs AND LYMPHOPROLIFERATIVE DISORDERS

  C Quadrelli, P Barozzi, G Riva, Mario Luppi

  e2011043

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.043

  1512

  PDF: 876

  HTML: 3144

• Therapy Outcome of a T-Cell-Rich-B-Cell Lymphoma (TCRBCL) Patient with Rituximab-CHOP in Ibadan, Nigeria: a Case Report.

  John Ayodele Olaniyi

  e2011008

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.008

  2569

  PDF: 638

  HTML: 1204

• THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY

  Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori

  e2012022

  2012-04-06

  https://doi.org/10.4084/mjhid.2012.022

  2344

  PDF: 938

  HTML: 1990

• TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY

  Agustin Avilès, Maria-Jesus Nambo, Natividad Neri

  e2018006

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.006

  4183

  PDF: 1172

  HTML: 919

• COINCIDENCE OR CONNECTION? REVISITING THE RELATIONSHIP BETWEEN MASTOCYTOSIS AND LYMPHOMA

  Antonio Frolli, Cristina Papayannidis, Carmen Fava, Martina Bullo, Selene Grano, Valentina Bonuomo, Daniela Gottardi, Guido Parvis, Beatrice Casadei, Daniela Cilloni

  e2026047

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.047

  343

  PDF: 284

  HTML: 43

• FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.

  Daniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, Varun Mehra, Pramila Krishnamurthy, Francesco Dazzi, Ye Ting Leung, Sandra Anteh, Mili Naresh Shah, Andrea Kuhnl, Robin Sanderson, Piers Patten, Deborah Yallop, Antonio Pagliuca, Victoria Potter

  e2023041

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.041

  1709

  PDF: 779

  HTML: 249

• LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B

  Eva Eliassen, Gerhard R Krueger, Mario Luppi, Dharam Ablashi

  e2018035

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.035

  3893

  PDF: 1672

  HTML: 873

  Figures . Eliassian: 273

• POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

  Daniela Capello, Gianluca Gaidano

  e2009018

  https://doi.org/10.4084/mjhid.2009.018

  1432

  PDF: 496

  HTML: 18632

  Figure 1: 201

  Figure 2: 185

  Figure 3: 197

  Figure 4: 230

  Figure 5: 205

• THE IMPORTANCE OF EPIGENETIC ALTERATIONS IN THE DEVELOPMENT OF EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

  Maria Takacs, Judit Segesdi, Ferenc Banati, Anita Koroknai, Hans Wolf, Hans Helmut Niller, Janos Minarovits

  e2009012

  https://doi.org/10.4084/mjhid.2009.012

  1135

  PDF: 549

  HTML: 3190

• CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

  omar ziad alrawi, fawzi abdel-latif abdel-rahman, rula alnajjar, husam abujazar, mourad salam, mustafa saad

  e2015049

  2015-08-25

  https://doi.org/10.4084/mjhid.2015.049

  1605

  PDF: 954

  HTML: 1024

  figures: 227

  table 1: 227

  table2: 230

  table3: 229

• IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

  Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop

  e2009010

  2009-11-13

  https://doi.org/10.4084/mjhid.2009.010

  1293

  PDF: 639

  HTML: 6934

• HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE

  Roberto Ria, Franco Dammacco, Angelo Vacca

  e2018011

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.011

  6800

  PDF: 1725

  HTML: 1568

• CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.

  Luciana Teofili, Immacolata Izzi, Eugenia Rosa Nuzzolo, Giancarlo Scoppettuolo, Katleen de Gaetano Donati, Lorenza Torti, Marianna Rossi

  e2012062

  2012-10-03

  https://doi.org/10.4084/mjhid.2012.062

  1742

  PDF: 773

  HTML: 1677

• CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2022069

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.069

  3412

  PDF: 995

  HTML: 3794

• The First Case of Concomitant Mycobacterium genavense lymphadenitis and EBV-positive lymphoproliferative disorder

  Yusuke Ito, Kensuke Takaoka, Kazuhiro Toyama, Yoshitaka Wakabayashi, Aya Shinozaki-Ushiku, Aiko Okazaki, Kinuyo Chikamatsu, Satoshi Mitarai, Tetsuo Ushiku, Mineo Kurokawa

  e2020035

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.035

  1260

  PDF: 779

  HTML: 325

• Simultaneous presentation of Hemophagocytic Lymphohistiocytosis and Classical Hodgkin's Lymphoma in a patient with underlying germline homozygous STXBP2 Mutation.

  Dr Shilpa Gupta, Dr Amrita Rajendran , Dr Akanksha Chichra , Dr Ayubali Qureshi

  e2026043

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.043

  341

  PDF: 233

  HTML: 82

• The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients

  Shuku Sato

  e2025070

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.070

  1503

  PDF: 504

  HTML: 257

• Chemotherapy-colchicine interaction in a child with Familial Mediterranean Fever and Hodgkin Lymphoma

  Karin Petra Sabine Langenberg-Ververgaert, Ronald M. Laxer, Angela S. Punnett, Lee L Dupuis, Yaron Finkelstein, Oussama Abla

  e2018019

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.019

  2969

  PDF: 901

  HTML: 477